Berry Genomics Co.,Ltd (SHE:000710)
9.92
+0.17 (1.74%)
Apr 29, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Revenue
In the year 2025, Berry Genomics Co.,Ltd had annual revenue of 929.82M CNY, down -13.76%. Berry Genomics Co.,Ltd had revenue of 244.16M in the quarter ending December 31, 2025, a decrease of -4.44%.
Revenue
929.82M
Revenue Growth
-13.76%
P/S Ratio
3.77
Revenue / Employee
663.21K
Employees
1,402
Market Cap
3.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 929.82M | -148.35M | -13.76% |
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medicalsystem Biotechnology | 1.54B |
| Guangdong Hybribio Biotech | 691.16M |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Chemclin Diagnostics | 353.32M |
| Thalys Medical Technology Group | 1.25B |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Shanghai Rendu Biotechnology | 161.94M |
| Cowealth Medical China | 656.38M |